Skip to main content

πŸ†• New CQC DOAC Monitoring Indicators

Updated over 2 weeks ago

We’ve added new CQC indicators for DOAC monitoring to make it easier to identify what’s missing for each patient and ensure reviews are completed safely and accurately.


πŸ” What’s new

The DOAC indicators have been split into separate parts so you can now see exactly which step of the monitoring process still needs to be done.

1️⃣ CQCDOAC001–004 β€” DOAC monitoring

These indicators cover all required review intervals (annual, 6-month, and 3-month checks, depending on kidney function).

Each now includes A and B versions:

Indicator Type

What it checks

Details

A indicators

Blood test (serum creatinine)

Confirms that a recent serum creatinine result is recorded for the patient.

B indicators

Creatinine clearance (CrCl)

Confirms that a CrCl has been calculated β€” this depends on having both a recent creatinine result and a weight.
⚠️ Patients won’t appear on the B indicator list until both results are recorded.

These indicators are:

  • CQCDOAC001 / 001A / 001B – Standard DOAC monitoring

  • CQCDOAC002 / 002A / 002B – Annual CrCl review

  • CQCDOAC003 / 003A / 003B – 3-month CrCl review (for CKD4/5)

  • CQCDOAC004 / 004A / 004B – 6-month CrCl review (for CKD3)


2️⃣ CQCDOAC000 β€” Weight recording

  • Checks that the patient has a weight recorded in the last 12 months.

  • Weight is required for accurate CrCl calculations β€” without it, CrCl (B) indicators will not appear or show as complete.


πŸ’‘ Why this matters

These changes make it easier to:

  • See which part of the DOAC review still needs to be completed (blood test, weight, or CrCl).

  • Ensure that creatinine clearance values are accurate and based on up-to-date data.

  • Stay compliant with CQC requirements for safe medicines monitoring.


πŸ“˜ Related indicators

  • CQCDOAC005 – Annual haemoglobin (patients on DOAC)

  • CQCDOAC007 – Appropriate kidney function


βœ… These indicators are now live and available for use in your Recall Campaigns.

Did this answer your question?